|
⚲
|
| Keyboard |
| Adjuvant Capital LP
✚
|
|
|---|---|
| CRD # | 301716 |
| SEC # | 801-118403 |
| CIK # | 0001935084 |
| AUM | |
| Employees | 5 (80% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 917-334-0724 |
| Address | 500 5th Avenue New York, NY 10110 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] |
| Total AUM ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Adjuvant Global Health Technology Fund de LP | [2020-03-10] | 48.2 M | 29.1 M |
| Offered $48,226,950 · Filed 2021-02-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Adjuvant Global Health Technology Fund LP | [2019-05-13] | 251.8 M | 152.4 M |
| Offered $251,773,050 · Filed 2021-02-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 268.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 268.0 |
| By Discretionary | ||
| Discretionary | 2 | 268.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 268.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 225.6 | |
| United States Persons | 42.5 | |
| Total | 2 | 268.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Jenny Yip | Executive Officer | 9 | 2 | |
| Glenn Rockman | Executive Officer | 6 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001935084] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Adjuvant Capital Management LLC | |
| Adjuvant Global Health Technology Fund LP | |
| Adjuvant Capital GP LP | |
| Adjuvant Global Health Technology Fund DE LP | |
| AN2 Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-01-16 | Sell | 84,093 | $19.65 | 1,652,427 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-01-16 | Sell | 15,907 | $19.65 | 312,573 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-11-14 | Sell | 288 | $16.15 | 4,651 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-11-14 | Sell | 1,522 | $16.15 | 24,580 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-10-02 | Sell | 4,770 | $16.07 | 76,654 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-10-02 | Sell | 902 | $16.07 | 14,495 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-29 | Sell | 15,764 | $16.28 | 256,638 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-29 | Sell | 83,337 | $16.28 | 1,356,726 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-28 | Sell | 7,160 | $16.11 | 115,348 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-28 | Sell | 1,356 | $16.11 | 21,845 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-27 | Sell | 707 | $16.07 | 11,361 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-27 | Sell | 134 | $16.07 | 2,153 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-13 | Sell | 64 | $16.00 | 1,024 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-13 | Sell | 336 | $16.00 | 5,376 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-07 | Sell | 2,841 | $16.05 | 45,598 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-07 | Sell | 537 | $16.05 | 8,619 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-06 | Sell | 598 | $16.02 | 9,580 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-09-06 | Sell | 3,164 | $16.02 | 50,687 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-08-23 | Sell | 336 | $16.00 | 5,376 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2023-08-23 | Sell | 64 | $16.00 | 1,024 |
| showing 20 of 22 most recent transactions | |||||